0.5744
price down icon21.40%   -0.1564
after-market Dopo l'orario di chiusura: .57 -0.0044 -0.77%
loading

Plus Therapeutics Inc Borsa (PSTV) Ultime notizie

pulisher
02:18 AM

Plus Therapeutics (PSTV.O) Plummets 15% – No Fundamentals, So What’s Behind It? - AInvest

02:18 AM
pulisher
12:03 PM

Plus Therapeutics (PSTV.O) Plunges 15% Amid No Fundamental Catalyst — What's Behind the Move? - AInvest

12:03 PM
pulisher
10:11 AM

Unpacking the Sharp Drop in Plus Therapeutics (PSTV.O): A Technical and Market-Flow Deep Dive - AInvest

10:11 AM
pulisher
06:35 AM

Plus Therapeutics receives extension to meet Nasdaq listing requirements - Investing.com

06:35 AM
pulisher
Aug 12, 2025

Plus Therapeutics Approves Key Proposals at Annual Meeting - MSN

Aug 12, 2025
pulisher
Aug 12, 2025

Plus Therapeutics Plunges 5.43% on Disappointing Q1 Earnings - AInvest

Aug 12, 2025
pulisher
Aug 11, 2025

Why Plus Therapeutics Inc. stock attracts strong analyst attentionOptimized Capital Rotation Picks - kangso.co.kr

Aug 11, 2025
pulisher
Aug 11, 2025

RSI Crosses Above 30 for Plus Therapeutics Inc. — Reversal in SightReversal Alert Based on RSI Indicator Confirmed - beatles.ru

Aug 11, 2025
pulisher
Aug 10, 2025

Plus Therapeutics PSTV 2025Q2 Earnings Preview Downside Ahead on Declining Revenue Expectations - AInvest

Aug 10, 2025
pulisher
Aug 08, 2025

Plus Therapeutics Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView

Aug 08, 2025
pulisher
Aug 08, 2025

Arch Therapeutics Inc. (ARTH) Product Pipeline Analysis, 2025 Update - GlobeNewswire Inc.

Aug 08, 2025
pulisher
Aug 07, 2025

Plus Therapeutics, Inc. shares rise 2.37% premarket after Almirall and Absci expand AI Drug Creation collaboration. - AInvest

Aug 07, 2025
pulisher
Aug 06, 2025

Plus Therapeutics Surges 17.46% on Breakthrough FDA Clearance and Strategic Funding Boost – What’s Next for PSTV? - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Plus Therapeutics shares rise 3.34% premarket after announcing a dose escalation phase 1 study for 186RNL. - AInvest

Aug 06, 2025
pulisher
Aug 03, 2025

How does Plus Therapeutics Inc. generate profit in a changing economyHarness the power of proven investment plans - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of Plus Therapeutics Inc. stockCapitalize on fast-moving stock opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in Plus Therapeutics Inc. stockUnlock real-time stock alerts for quick profits - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Plus Therapeutics Inc. stockConsistent triple-digit returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What makes Plus Therapeutics Inc. stock price move sharplyFree High-Return Strategy Alerts - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about Plus Therapeutics Inc. stockGet timely advice on market trends - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What drives Plus Therapeutics Inc. stock priceExtraordinary earning power - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

How strong is Plus Therapeutics Inc. company’s balance sheetTop Growth Trend Scanner With High Returns - jammulinksnews.com

Aug 02, 2025
pulisher
Aug 01, 2025

Published on: 2025-08-01 22:18:13 - metal.it

Aug 01, 2025
pulisher
Aug 01, 2025

Plus Therapeutics (PSTV.O) Surges 16.5% — What's Behind the Sharp Move? - AInvest

Aug 01, 2025
pulisher
Aug 01, 2025

Plus Therapeutics’ Innovative Study on Rhenium-186 NanoLiposome for Cancer Metastases - TipRanks

Aug 01, 2025
pulisher
Jul 31, 2025

What are analysts’ price targets for Plus Therapeutics Inc. in the next 12 monthsStock Strategy Recommendation From AI Tools - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Plus Therapeutics Provides US Launch Update for its CNSide® Diagnostic - GlobeNewswire

Jul 31, 2025
pulisher
Jul 31, 2025

Plus Therapeutics (PSTV) to Introduce CNSide Diagnostics in Texas by August 2025 - GuruFocus

Jul 31, 2025
pulisher
Jul 31, 2025

Plus Therapeutics Provides US Launch Update for its CNSide® Diag - GuruFocus

Jul 31, 2025
pulisher
Jul 31, 2025

Revolutionary CNS Cancer Test With 92% Accuracy Launches at Major Texas Cancer Centers - Stock Titan

Jul 31, 2025
pulisher
Jul 30, 2025

Is Plus Therapeutics Inc. stock overvalued or undervaluedReal Time Watchlist With Proven Results - jammulinksnews.com

Jul 30, 2025
pulisher
Jul 30, 2025

Plus Therapeutics (PSTV.O) Plunges 13%: Unpacking the Intraday Shock - AInvest

Jul 30, 2025
pulisher
Jul 29, 2025

Institutional Tools Highlight Unusual Flow in Plus Therapeutics Inc.Watchlist for Smart Swing Trading Updated - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Does Plus Therapeutics Inc. stock perform well during market downturnsBuild wealth steadily with proven investment techniques - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Why is Plus Therapeutics Inc. stock attracting strong analyst attentionAmplify your gains with low-risk picks - Jammu Links News

Jul 28, 2025
pulisher
Jul 27, 2025

What catalysts could drive Plus Therapeutics Inc. stock higher in 2025Unlock rapid growth potential in your portfolio - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How volatile is Plus Therapeutics Inc. stock compared to the marketConsistent wealth multiplication - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-27 20:49:15 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

Healthcare Stocks Move in Intrday Session: Gainers and Losers - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

Should I buy Plus Therapeutics Inc. stock before earningsRecord-setting profit potential - jammulinksnews.com

Jul 25, 2025
$36.46
price up icon 1.67%
$85.87
price up icon 5.22%
$26.86
price up icon 4.59%
$122.87
price up icon 0.71%
$112.78
price up icon 1.60%
biotechnology ONC
$307.51
price up icon 6.74%
Capitalizzazione:     |  Volume (24 ore):